Jia-Rong Li

11:40 Federico Torta
Quantitative Measurements of Circulating Ceramides as Markers for Cardiometabolic Disorders
12:10 Ruben Luo
Determination of Clonality of Monoclonal Serum Free Light Chains by On-Probe Extraction Coupled with Liquid Chromatography-Mass Spectrometry
12:25 Jia-Rong Li
Exploring Serum Amyloid A Variant Barcode in Colorectal Cancer by Nanoprobe-based Affinity Mass Spectrometry
12:40 Daisuke Nakajima
A novel newborn screening modality: Non-targeted proteome analysis using low-cost iron powders

Organized by Hsiao-Wei Liao (National Yang Ming Chiao Tung University, Taiwan) and Masamitsu Maekawa (Tohoku University, Japan)
Mass spectrometry has been used in chemical diagnosis of diseases due to its usefulness in measuring various biomolecules. Furthermore, it has also been put to good use in the quantitative analysis of pharmaceuticals in recent years, and is contributing to more precise medical care. In addition, many new studies of pathological molecular mechanisms have been discovered through reverse translational research based on the results of clinical research. The aim of this session is to discuss the frontier of clinical mass spectrometry in chemical diagnosis and optimization of patient treatment, as well as in reverse translational research.